Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Lack of toxicity data and poor physicochemical properties must be overcome. More than 25% of drugs on the market worldwide and candidates in the pharmaceutical pipeline were considered to be ...